3D Cell Culture Global Market - Forecast to 2021

  • ID: 3517865
  • Report
  • Region: Global
  • 303 Pages
  • IQ4I Research & Consultancy Pvt. Ltd
1 of 6
The 3D Cell Culture Global Market Is Poised to Grow at a Double Digit CAGR to Reach $3,702.2 Million by 2021

FEATURED COMPANIES

  • 300 Microns GmbH
  • BRTI Life Sciences
  • Diagenode s.a.
  • Invitrogen
  • Molecular matrix
  • Scivax Life Sciences, Inc
  • MORE
3D cell culture is accepted as a new dimension of cell culture sector in biomedical research field. Cells grown on two-dimensional (2D) substrates do not represent true in-vivo cell environment and lack extracellular components, cell-cell and cell-matrix interactions necessary for differentiation, proliferation and cell-based functions.

Hence, now-a-days three-dimensional (3D) cell culture methods are much preferred over 2D models as they provide a matrix support that encourages cells to organize into structures more indicative of the in--vivo environment and help to overcome 2D related shortcomings.

Increased use of 3D cell culture systems bring the hope of lowering lead molecule attrition rates but however, these models restricts huge data reproducibility, challenge assay readout systems and do not contain all cells relevant for tumour environment. In addition, the favourable artificial environment created by 3D model enables longer-term dosing experiments for analyzing drug’s cumulative effects.

The 3D cell culture global market is poised to grow at a double digit CAGR to reach $3,702.2 million by 2021. The 3D cell culture market is classified based on type, applications, end-users and geography. The 3D cell culture by technology is segmented into scaffold based platform, scaffold free platform, bioreactors, microchips and hydrogels.

Scaffold based platform is sub-segmented into natural scaffold, synthetic scaffold and hybrid composite. Natural scaffold is in-turn classified into protein based biomaterials (collagen, fibrin, silk, gelatin, elastin, keratin, actin and myosin, laminin and vitronectin) and polysaccharide based biomaterials (Agarose, alginate, hyaluronan, chitosan, amylase, dextran, cellulose and glycosaminoglycans).

The synthetic scaffold is divided into polymer based biomaterials (Poly (lactic-co-glycolic acid), Polyethylene glycol, Polylactic acid, Polyglycolic acid, Polycapro lactone and polystyrene), peptide based biomaterials, ceramic based biomaterials (hydroxyapatite and bioactive glass) and metal based biomaterials (aluminium and titanium).

Scaffold free platform is sub-divided into low attachment surface, hanging drop method and microfluidics. The bioreactors segment consists of spinner flask, rotating wall vessel and perfusion bioreactors. The 3D cell culture consumables section contains cells and tissues, media and sera and reagent.

Further, the 3D culture market by application includes basic research, toxicity and drug safety screening, tissue engineering, stem cell research, drug discovery, gene therapy and cancer research. The 3D cell culture market is segmented into research laboratories and institutes, biotechnology and pharmaceutical industries, hospitals and diagnostic centers and others.

Finally, the 3D cell culture market is classified by geographical regions into North America, Europe, Asia-Pacific and Rest of the World.

READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • 300 Microns GmbH
  • BRTI Life Sciences
  • Diagenode s.a.
  • Invitrogen
  • Molecular matrix
  • Scivax Life Sciences, Inc
  • MORE
1 Executive Summary

2 Introduction
2.1 Key Take Aways
2.2 Report Description
2.3 Markets Covered
2.4 Stakeholders
2.5 Research Methodology
2.5.1 Market Size Estimation
2.5.2 Market Crackdown And Data Triangulation
2.5.3 Secondary Sources
2.5.4 Key Data Points From Secondary Sources
2.5.5 Primary Sources
2.5.6 Key Data Points From Primary Sources
2.5.7 Assumptions

3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers And Opportunities
3.3.1.1 Rise In Research And Development Investments
3.3.1.2 Rising Need For Organ Transplantation
3.3.1.3 Use Of 3D Cell Culture Models As A Tool Against Animal Testing
3.3.1.4 Use Of Microfluidic Technology
3.3.1.5 Increasing Focus On Regenerative Medicine
3.3.2 Restraints And Threats
3.3.2.1 Lack Of Experienced And Skilled Professionals
3.3.2.2 Budget Restriction For Small And Medium Sized Laboratories.
3.3.2.3 Lack Of Consistency In 3D Cell Culture Products
3.3.2.4 Stringent Process Controls For Advanced Handling Capabilities
3.3.2.5 Ethical Concern Over Use Of Animal Sources
3.4 Regulatory Affairs
3.4.1 United States
3.4.2 Europe
3.4.3 India
3.4.4 Japan
3.5 Technological Advancements
3.5.1 Introduction
3.5.2 Organ-On-Chip
3.5.3 3D Bioprinting
3.5.4 3D Vascularized Organs
3.5.5 Mimetix 3D Cell Culture Scaffolds
3.5.6 Nano Culture Plates
3.6 Upcoming Technologies
3.7 Approved Biomaterials
3.8 Porter’S Five Force Analysis
3.8.1 Threat Of New Entrants
3.8.2 Threat Of Substitutes
3.8.3 Bargaining Power Of Suppliers
3.8.4 Bargaining Power Of Buyers
3.8.5 Rivalry Among Existing Competitors
3.9 Market Share Analysis By Major Players

4 3D Cell Culture Global Market, By Type
4.1 Introduction
4.2 By Technology
4.2.1 Introduction
4.2.2 Scaffold Based Platform
4.2.2.1 Natural Scaffolds
4.2.2.1.1 Protein Based Biomaterials
4.2.2.1.1.1 Collagen
4.2.2.1.1.2 Fibrin
4.2.2.1.1.3 Silk
4.2.2.1.1.4 Gelatin
4.2.2.1.1.5 Elastin
4.2.2.1.1.6 Keratin
4.2.2.1.1.7 Laminin
4.2.2.1.1.8 Vitronectin
4.2.2.1.2 Polysaccharide Based Biomaterials
4.2.2.1.2.1 Agarose
4.2.2.1.2.2 Alginate
4.2.2.1.2.3 Hyaluronan
4.2.2.1.2.4 Chitosan
4.2.2.1.2.5 Dextran
4.2.2.1.2.6 Cellulose
4.2.2.1.2.7 Glycosaminoglycans
4.2.2.2 Synthetic Scaffolds
4.2.2.2.1 Polymer Based Biomaterials
4.2.2.2.1.1 Plga [Poly (Lactic-Co-Glycolic Acid)]
4.2.2.2.1.2 Peg (Polyethylene Glycol)
4.2.2.2.1.3 Pla (Polylactic Acid)
4.2.2.2.1.4 Ps (Polystyrene)
4.2.2.2.1.5 Pcl (Polycapro Lactone)
4.2.2.2.2 Peptide Based Biomaterials
4.2.2.2.3 Ceramic Based Biomaterials
4.2.2.2.3.1 Hydroxyapatite (Ha)
4.2.2.2.3.2 Bioactive Glass
4.2.2.2.4 Metal Based Biomaterial
4.2.2.2.4.1 Aluminium
4.2.2.2.4.2 Titanium
4.2.2.3 Hybrid Composite
4.2.3 Scaffold Free Platform
4.2.3.1 Low Attachment Surface
4.2.3.2 Hanging Drop Method
4.2.3.3 Microfluidics
4.2.4 Bioreactors
4.2.4.1 Spinner Flasks
4.2.4.2 Rotating Wall Vessels (Rwv)
4.2.4.3 Perfusion Bioreactors
4.2.5 Microchips
4.2.6 Hydrogels
4.3 By Consumables
4.3.1 Introduction
4.3.2 Cells And Tissues
4.3.3 Media And Sera
4.3.4 Microplate And Reagents
4.3.5 Assay Kits

5 3D Cell Culture Global Market, By Applications
5.1 Introduction
5.2 Basic Research
5.3 Toxicity And Drug Safety Screening
5.4 Tissue Engineering
5.5 Stem Cell Research
5.6 Drug Discovery
5.7 Cancer Research
5.8 Gene Therapy

6 3D Cell Culture Global Market, By End Users
6.1 Introduction
6.2 Academic Institutes
6.3 Biotechnology And Pharmaceutical Industries
6.4 Hospitals And Diagnostic Centers
6.5 Others

7 Regional Analysis
7.1 Introduction
7.2 North America
7.3 Europe
7.4 Asia-Pacific
7.5 Rest Of The World

8 Competitive Landscape
8.1 Introduction
8.2 New Product Launches
8.3 Agreements, Partnership, Collaboration & Joint Ventures
8.4 Expansions, Appovals And Service Launches
8.5 Mergers & Acquisitions

9 Major Companies
9.1 3D Biomatrix
9.1.1 Overview
9.1.2 Financials
9.1.3 Products Portfolio
9.1.4 Key Developments
9.1.5 Business Strategy
9.1.6 Swot Analysis
9.2 3D Biotek Llc
9.2.1 Overview
9.2.2 Financials
9.2.3 Product Portfolio
9.2.4 Key Developments
9.2.5 Business Strategy
9.2.6 Swot Analysis
9.3 Becton, Dickinson And Company
9.3.1 Overview
9.3.2 Financials
9.3.3 Product Portfolio
9.3.4 Key Developments
9.3.5 Business Strategy
9.3.6 Swot Analysis
9.4 Corning Incorporated
9.4.1 Overview
9.4.2 Financials
9.4.3 Product Portfolio
9.4.4 Key Developments
9.4.5 Business Strategy
9.4.6 Swot Analysis
9.5 Global Cell Solutions, Inc
9.5.1 Overview
9.5.2 Financials
9.5.3 Product Portfolio
9.5.4 Key Developments
9.5.5 Business Strategy
9.5.6 Swot Analysis
9.6 Insphero Ag
9.6.1 Overview
9.6.2 Financials
9.6.3 Product Portfolio
9.6.4 Key Developments
9.6.5 Business Strategy
9.6.6 Swot Analysis
9.7 Lonza Group
9.7.1 Overview
9.7.2 Financials
9.7.3 Product Portfolio
9.7.4 Key Developments
9.7.5 Business Strategy
9.7.6 Swot Analysis
9.8 Nano 3D Biosciences, Inc
9.8.1 Overview
9.8.2 Financials
9.8.3 Product Portfolio
9.8.4 Key Developments
9.8.5 Business Strategy
9.8.6 Swot Analysis
9.9 Nanofiber Solutions
9.9.1 Overview
9.9.2 Financials
9.9.3 Product Portfolio
9.9.4 Key Developments
9.9.5 Business Strategy
9.9.6 Swot Analysis
9.10 Reprocell Incorporated
9.10.1 Overview
9.10.2 Financials
9.10.3 Product Portfolio
9.10.4 Key Developments
9.10.5 Business Strategy
9.10.6 Swot Analysis
9.11 Sigma Aldrich Corporation
9.11.1 Overview
9.11.2 Financials
9.11.3 Product Portfolio
9.11.4 Key Developments
9.11.5 Business Strategy
9.11.6 Swot Analysis
9.12 Thermo Fisher Scientific, Inc
9.12.1 Overview
9.12.2 Financials
9.12.3 Product Portfolio
9.12.4 Key Developments
9.12.5 Business Strategy
9.12.6 Swot Analysis

List Of Tables
Table 1 3D Cell Culture Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 2 3D Cell Culture Global Market Revenue, By Type, (2013-2021) ($Mn)
Table 3 3D Cell Culture Technology Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 4 3D Cell Culture Technology Global Market Revenue, By Type, (2013-2021) ($Mn)
Table 5 3D Cell Culture Scaffold Based Platform Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 6 3D Cell Culture Scaffold Based Platform Global Market Revenue, By Type, (2013-2021) ($Mn)
Table 7 3D Cell Culture Natural Scaffolds Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 8 3D Cell Culture Synthetic Scaffolds Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 9 3D Cell Culture Hybrid Composite Scaffolds Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 10 3D Cell Culture Scaffold Free Platforms Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 11 3D Cell Culture Scaffold Free Platforms Global Market Revenue, By Type, (2013-2021) ($Mn)
Table 12 Low Attachment Surface Scaffold Free Platforms Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 13 Hanging Drop Method Scaffold Free Platforms Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 14 Microfluidics Scaffold Free Platforms Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 15 3D Cell Culture Biorectors Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 16 3D Cell Culture Bioreactors Global Market Revenue, By Type, (2013-2021) ($Mn)
Table 17 3D Cell Culture Spinner Flask Bioreactors Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 18 3D Cell Culture Rotating Wall Vessel Bioreactors Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 19 3D Cell Culture Perfusion Bioreactors Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 20 3D Cell Culture Microchips Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 21 3D Cell Culture Hydrogels Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 22 3D Cell Culture Consumables Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 23 3D Cell Culture Consumables Global Market Revenue, By Type, (2013-2021) ($Mn)
Table 24 3D Cell Culture Cells And Tissue Consumables Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 25 3D Cell Culture Media And Sera Consumables Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 26 3D Cell Culture Microplate And Reagent Consumables Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 27 3D Cell Culture Assay Kits Consumables Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 28 3D Cell Culture Global Market Revenue, By Applications, (2013-2021) ($Mn)
Table 29 3D Cell Culture Basic Research Application Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 30 3D Cell Culture Toxicity And Drug Safety Screening Application Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 31 3D Cell Culture Tissue Engineering Applications Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 32 3D Cell Culture Stem Cell Research Applications Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 33 3D Cell Culture Drug Discovery Applications Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 34 3D Cell Culture Cancer Research Applications Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 35 3D Cell Culture Gene Therapy Applications Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 36 3D Cell Culture Global Market Revenue, By End-Users, (2013-2021) ($Mn)
Table 37 3D Cell Culture Academic Institutes End-Users Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 38 3D Cell Culture Biotechnology And Pharmaceuticals Industries End-Users Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 39 3D Cell Culture Hospitals And Diagnostic Centres End-User Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 40 3D Cell Culture Other End-Users Global Market Revenue, By Region, (2013-2021) ($Mn)
Table 41 3D Cell Culture Global Market Revenue,By Region, (2013-2021) ($Mn)
Table 42 North American 3D Cell Culture Market Revenue, By Type, (2013-2021) ($Mn)
Table 43 North American 3D Cell Culture Technology Market Revenue, By Type, (2013-2021) ($Mn)
Table 44 North American 3D Cell Culture Bioreactors Market Revenue, By Type, (2013-2021) ($Mn)
Table 45 North American 3D Cell Culture Scaffold Based Platforms Market Revenue, By Type, (2013-2021) ($Mn)
Table 46 North American 3D Cell Culture Scaffold Free Market Revenue, By Type, (2013-2021) ($Mn)
Table 47 North American 3D Cell Culture Consumables Market Revenue, By Type, (2013-2021) ($Mn)
Table 48 North American 3D Cell Culture Market Revenue, By Applications, (2013-2021) ($Mn)
Table 49 North American 3D Cell Culture Market Revenue, By End-User, (2013-2021) ($Mn)
Table 50 European 3D Cell Culture Market Revenue, By Type, (2013-2021) ($Mn)
Table 51 European 3D Cell Culture Technology Market Revenue, By Type, (2013-2021) ($Mn)
Table 52 European 3D Cell Culture Bioreactors Market Revenue, By Type, (2013-2021) ($Mn)
Table 53 European 3D Cell Culture Scaffold Based Platforms Market Revenue, By Type, (2013-2021) ($Mn)
Table 54 European 3D Cell Culture Scaffold Free Market Revenue, By Type, (2013-2021) ($Mn)
Table 55 European 3D Cell Culture Consumables Market Revenue, By Type, (2013-2021) ($Mn)
Table 56 European 3D Cell Culture Market Revenue, By Application, (2013-2021) ($Mn)
Table 57 European 3D Cell Culture Market Revenue, By End-User, (2013-2021) ($Mn)
Table 58 Asia-Pacific 3D Cell Culture Market Revenue, By Type, (2013-2021) ($Mn)
Table 59 Asia-Pacific 3D Cell Culture Technology Market Revenue, By Type, (2013-2021) ($Mn)
Table 60 Asia-Pacific 3D Cell Culture Bioreactors Market Revenue, By Type, (2013-2021) ($Mn)
Table 61 Asia-Pacific 3D Cell Culture Scaffold Based Platforms Market Revenue, By Type, (2013-2021) ($Mn)
Table 62 Asia-Pacific 3D Cell Culture Scaffold Free Market Revenue, By Type, (2013-2021) ($Mn)
Table 63 Asia-Pacific 3D Cell Culture Consumables Market Revenue, By Type, (2013-2021) ($Mn)
Table 64 Asia-Pacific 3D Cell Culture Market Revenue, By Application, (2013-2021) ($Mn)
Table 65 Asia-Pacific 3D Cell Culture Market Revenue, By End Users, (2013-2021) ($Mn)
Table 66 Rest Of The World 3D Cell Culture Market Revenue, By Type, (2013-2021) ($Mn)
Table 67 Rest Of The World 3D Cell Culture Technology Market Revenue By Type, (2013-2021) ($Mn)
Table 68 Rest Of The World 3D Cell Culture Bioreactors Market Revenue, By Type, (2013-2021) ($Mn)
Table 69 Rest Of The World 3D Cell Culture Scaffold Based Platforms Market Revenue, By Type, (2013-2021) ($Mn)
Table 70 Rest Of The World 3D Cell Culture Scaffold Free Market Revenue, By Type, (2013-2021) ($Mn)
Table 71 Rest Of The World 3D Cell Culture Consumables Market Revenue, By Type, (2013-2021) ($Mn)
Table 72 Rest Of The World 3D Cell Culture Market Revenue, By Application, (2013-2021) ($Mn)
Table 73 Rest Of The World 3D Cell Culture Market Revenue, By End-User, (2013-2021) ($Mn)
Table 74 New Product Launches (2013-2015)
Table 75 Agreements, Partnership, Collaboration & Joint Ventures (2013-2015)
Table 76 Expansions, Approvals And Service Launch (2013-2015)
Table 77 Mergers & Acquisitions (2013-2015)
Table 78 Becton, Dickinson And Company: Total Revenue And R&D Expenses (2012-2014) ($Mn)
Table 79 Becton, Dickinson And Company: Total Revenue, By Segments (2012-2014) ($ Mn)
Table 80 Becton, Dickinson And Company: Total Revenue, By Geography (2012-2014) ($ Mn)
Table 81 Corning Incorporated: Total Revenue And R&D Expenses, (2012-2014) ($Mn)
Table 82 Corning Incorporated: Total Revenue, By Segment, (2012-2014) ($Mn)
Table 83 Corning Incorporated: Total Revenue, By Geography, (2012-2014) ($Mn)
Table 84 Lonza Group: Total Revenue And R&D Expenses (2012-2014) ($Mn)
Table 85 Lonza Group: Total Revenue, By Segments (2012-2014) ($Mn)
Table 86 Lonza Group: Total Revenue, By Geography (2012-2014) ($Mn)
Table 87 Sigma Aldrich’S: Total Revenue And R&D Expenses, (2012-2014) ($Mn)
Table 88 Sigma Aldrich’S: Total Revenue, By Segments, (2012-2014) ($Mn)
Table 89 Sigma Aldrich’S: Total Revenue, By Geography, (2012-2014) ($Mn)
Table 90 Thermo Fisher Scientific, Inc: Total Revenue And R&D Expenses, (2012-2014) ($Mn)
Table 91 Thermo Fisher Scientific, Inc : Total Revenue, By Segments, (2012-2014) ($Mn)
Table 92 Thermo Fisher Scientific, Inc: Total Revenue, By Geography, (2012-2014) ($Mn)

List Of Figures
Figure 1 Global 3D Cell Culture Market Share And Revenue, By Region, (2013-2021) ($Mn)
Figure 2 3D Cell Culture Market: Research Approach
Figure 3 3D Cell Culture Market: Top-Down And Bottom-Up Approach
Figure 4 3D Cell Culture Market: Forecasting Model
Figure 5 3D Cell Culture Market: Market Crackdown And Data Triangulation
Figure 6 3D Cell Culture Global Market: Market Segmentation
Figure 7 Market Dynamics
Figure 8 3D Cell Culture Market: Porter’S Analysis
Figure 9 3D Cell Culture Global Market Share Analysis, By Key Players, 2014
Figure 10 3D Cell Culture Global Market Revenue, By Type (2013-2021) ($Mn)
Figure 11 3D Cell Culture Technology Global Market Share, By Type, (2014 V’S 2021) (%)
Figure 12 Scaffold Based Platforms Global Market Size, By Type (2014) (%)
Figure 13 Scaffold Free Platforms Global Market Revenue, By Type, (2014) ($Mn)
Figure 14 3D Cell Culture Consumables Global Market Revenue, By Type, (2014 V’S 2021) ($Mn)
Figure 15 3D Cell Culture Global Market Revenue, By Application, (2014) (%)
Figure 16 3D Cell Culture Global Market Revenue, By End-Users, (2013-2021) ($Mn)
Figure 17 3D Cell Culture Global Market Revenue, By Region, (2013-2021) ($Mn)
Figure 18 North American 3D Cell Culture Market Revenue, By Technology, Consumables, Application & End-Users, (2014 V’S 2021) ($Mn)
Figure 19 European 3D Cell Culture Market Revenue, By Technology, Consumables, Application & End-Users, (2014 V’S 2021) ($Mn)
Figure 20 Asia-Pacific 3D Cell Culture Market Revenue, By Technology, Consumables, Application & End-Users, (2014 V’S2021) ($Mn)
Figure 21 Rest Of The World 3D Cell Culture Market Revenue, By Technology, Consumables, Application & End-Users, (2014 V’S 2021) ($Mn)
Figure 22 Key Growth Strategies, (2013 – 2015)
Figure 23 Swot: 3D Biomatrix
Figure 24 Swot: 3D Biotek
Figure 25 Swot: Becton, Dickinson And Company
Figure 26 Swot: Corning Incorporated
Figure 27 Swot: Global Cell Solutions
Figure 28 Swot: Insphero Ag
Figure 29 Swot: Lonza Group
Figure 30 Swot: Nano 3D Biosciences
Figure 31 Swot: Nanofiber Solution
Figure 32 Swot: Reprocell
Figure 33 Swot: Sigma Aldrich
Figure 34 Swot: Thermo Fisher Scientific, Inc

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • 300 Microns GmbH
  • BRTI Life Sciences
  • Diagenode s.a.
  • Invitrogen
  • Molecular matrix
  • Scivax Life Sciences, Inc
  • MORE
The first attempt to culture cell artificially dates back to late 1907, where Dr. Ross Harrison, an Anatomy Professor, developed hanging drop technique to growing three-dimensional frog embryonic nerve fragments via a coverslip. Since then, life science researchers have depended on primarily adherent, two-dimensional (2D) cell culture techniques where cells of interest are cultured in plastic or glassware for study of human cells, tissues, and disease
models.

As intricacies of these techniques are understood, advanced 3-dimensional models have been developed which greatly influence the in-vitro culturing and driving cell culture market. In contrast to 2D environment, cells grown in three-dimensions display higher degree of intercellular interactions, assume more physiologically relevant morphologies and preserve higher-order tissue processes. Tools, technologies, and protocols are making invitro 3D analysis simple, cheap, reproducible and scalable-enough for adaptation in drug development.

As these tools have become more accessible and validated, researchers in both academia and biopharma are shifting their attention from 2D to 3D cell culture. Rising investments in research and development, increasing need for organ transplantation, use of 3D cell culture models as a tool against animal testing, use of microfluidic technology, and increasing focus on regenerative medicine are some of the factors that are driving the market growth.

Whereas, Lack of experienced and skilled medical professionals, lack of consistency in 3D cell culture products and budget restriction for small and medium-sized laboratories are hindering the market growth. Stringent regulatory process controls and ethical concern over animal source usage are the major threat to the market. The entry of new players with novel technologies and introduction of technology driven products are creating an opportunity in the global 3D cell culture market.
Note: Product cover images may vary from those shown
5 of 6
- 300 Microns GmbH
- 3D Biomatrix, Inc
- 3D Biotek LLC
- 3D Matrix
- 3DTro AB
- AIM Biotech PTE Ltd. Singapore
- AMS Biotechnology (Europe) Ltd
- Advanced Biomatrix
- AmsBio
- Asterand Bioscience
- BRTI Life Sciences
- Becton, Dickinson and Company
- Bellco Glass, Inc
- Berkeley Advanced Biomaterials
- Biolamina
- Bioneer A/S
- BrandTech Scientific,Inc
- Celartia Ltd.
- Celenys
- Cell spring
- Cellec Biotek AG
- Cellendes GmbH
- Celprogen
- Corning Incorporated
- Cosmobio
- CyGenics Ltd
- Cyfuse Biomedical KK
- Cytomatrix LLC
- Diagenode s.a.
- DiagnoCine
- ESI Bio
- Ectica Technologies AG
- Electrospinning Company
- Fluidinova SA
- Genlantis
- Global Cell Solutions, Inc
- Glycosan BioSystems, Inc
- Gradientech AB
- IKKO-ZU Corporation
- IV Tech Srl
- Insphero AG
- InvitroCue
- Invitrogen
- Ixchel scientific
- Keranetics
- Lena Biosciences
- Lonza Group
- Matricel
- Merck Millipore
- Microtiss
- Miltenyi Biotec
- Mimetas
- Mirus Bio LLC
- Molecular matrix
- Nano 3D Biosciences
- Nanofiber Solutions Incorporated
- Nanopharma
- Novamatrix
- Oncotest GmbH
- Organovo Holdings, Inc
- Pepgel LLC
- Pharma Cosmos
- Promega
- Prosys Prohealthcare System
- Reinnervate Ltd
- Rejuvel Bio-Sciences, Inc
- SGH Sciences
- Sangi Co., Ltd.
- Scivax Life Sciences, Inc
- Shibuya Corporation
- Sigma Aldrich Corporation
- Stem Cell Technologies
- Synthecon, Inc
- TETEC AG
- Tecan
- Thermo Fisher Scientific
- Thomas Scientific
- Toyo Gosei Co., Ltd.
- TransGenex Nanobiotech, Inc.
- UniQure BV
- Vivo Biosciences Inc.
- Vornia Biomaterials
- Wheaton Science Products
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll